Markets
markets
Luke Kawa

Weed stocks soar after Trump reposts video touting CBD products as the “most important senior health initiative of the century”

Weed stocks are roaring out of the gate on Monday morning after President Donald Trump reposted a video from The Commonwealth Project detailing the benefits of hemp-derived CBD products for seniors as the “most important senior health initiative of the century.”

Canopy Growth, Tilray, SNDL Inc., and Cronos Group are all up between 10% and 20% as of 7 a.m. ET.

The clip says that hemp-derived CBD products offer relief from pain, inflammation, and cognitive decline faster than “dangerous and addictive” pharmaceuticals or tweaks to diet and lifestyle. This can “add years to your life,” per The Commonwealth Project, which bills itself as “working to prioritize the 65+ population by integrating medical cannabis into mainstream health care for seniors.”

The roughly three-minute-long video focuses on hemp-derived CBD products, but it also includes a clip from Fox News that claims annual cost savings to the US of nearly $64 billion per year if cannabis is fully integrated into the healthcare system.

Over the past couple of months, marijuana stocks have been powered by the potential for the Trump administration to reclassify marijuana as a less dangerous drug, which news reports and the president himself have suggested is under consideration.

The Commonwealth Project’s video hails the 2018 Farm Bill signed by Trump in his first term (which legalized hemp production at the federal level) as a “first step,” but also calls for Medicare coverage for CBD to “give millions of seniors the support they deserve.”

More Markets

See all Markets
markets

SpaceX gets a wave of bullish ratings from Wall Street analysts

SpaceX received more than a dozen positive analyst calls on Tuesday — including from major Wall Street banks — as they initiate coverage on Elon Musk’s space and AI company.

SpaceX went public on June 12 at a $2.2 trillion valuation, the largest debut in history. While the company hasn’t yet posted a profit, it seems to have convinced Wall Street that it will get there and grow its valuation on the way.

Of the at least 17 analysts that gave a rating on Tuesday, all but one gave it a “buy” or “outperform” rating. MoffettNathanson was "neutral."

The ratings come as SpaceX joined the Nasdaq 100 index, a benchmark tech-heavy basket of companies that underpins millions of portfolios. The inclusion adds built-in demand for the stock from index funds and ETFs.

Still, SpaceX fell more than 5% on Tuesday amid a broader sell-off, and is currently effectively flat from its opening price of $150 a share.

Latest Stories

Sherwood Media, LLC and Chartr Limited produce fresh and unique perspectives on topical financial news and are fully owned subsidiaries of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Money, LLC, Robinhood U.K. Ltd, Robinhood Derivatives, LLC, Robinhood Gold, LLC, Robinhood Asset Management, LLC, Robinhood Credit, Inc., Robinhood Ventures DE, LLC and, where applicable, its managed investment vehicles.